DK4121419T3 - Kokrystaller af (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentancarboxylsyre - Google Patents

Kokrystaller af (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentancarboxylsyre Download PDF

Info

Publication number
DK4121419T3
DK4121419T3 DK21710531.1T DK21710531T DK4121419T3 DK 4121419 T3 DK4121419 T3 DK 4121419T3 DK 21710531 T DK21710531 T DK 21710531T DK 4121419 T3 DK4121419 T3 DK 4121419T3
Authority
DK
Denmark
Prior art keywords
cocrystals
ylcarbamoyl
thiazol
cyano
phenyl
Prior art date
Application number
DK21710531.1T
Other languages
Danish (da)
English (en)
Inventor
Gómez Juan Camacho
Laria Julio Castro Palomino
Original Assignee
Palobiofarma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palobiofarma Sl filed Critical Palobiofarma Sl
Application granted granted Critical
Publication of DK4121419T3 publication Critical patent/DK4121419T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/02—Salts; Complexes; Addition compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK21710531.1T 2020-03-16 2021-03-15 Kokrystaller af (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentancarboxylsyre DK4121419T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20382194.7A EP3882240A1 (en) 2020-03-16 2020-03-16 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid
PCT/EP2021/056506 WO2021185748A1 (en) 2020-03-16 2021-03-15 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid

Publications (1)

Publication Number Publication Date
DK4121419T3 true DK4121419T3 (da) 2024-10-28

Family

ID=69953938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK21710531.1T DK4121419T3 (da) 2020-03-16 2021-03-15 Kokrystaller af (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentancarboxylsyre

Country Status (21)

Country Link
US (1) US12384754B2 (cg-RX-API-DMAC10.html)
EP (2) EP3882240A1 (cg-RX-API-DMAC10.html)
JP (1) JP7779846B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220154791A (cg-RX-API-DMAC10.html)
CN (1) CN115298169B (cg-RX-API-DMAC10.html)
AU (1) AU2021237686B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022018449A2 (cg-RX-API-DMAC10.html)
CA (1) CA3171894C (cg-RX-API-DMAC10.html)
DK (1) DK4121419T3 (cg-RX-API-DMAC10.html)
ES (1) ES3002084T3 (cg-RX-API-DMAC10.html)
FI (1) FI4121419T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20241515T1 (cg-RX-API-DMAC10.html)
HU (1) HUE068886T2 (cg-RX-API-DMAC10.html)
LT (1) LT4121419T (cg-RX-API-DMAC10.html)
MX (1) MX2022011530A (cg-RX-API-DMAC10.html)
PL (1) PL4121419T3 (cg-RX-API-DMAC10.html)
PT (1) PT4121419T (cg-RX-API-DMAC10.html)
RS (1) RS66214B1 (cg-RX-API-DMAC10.html)
SI (1) SI4121419T1 (cg-RX-API-DMAC10.html)
WO (1) WO2021185748A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202211247B (cg-RX-API-DMAC10.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331220B1 (es) * 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
WO2011158110A2 (en) 2010-04-28 2011-12-22 Nuformix Limited Cilostazol cocrystals and compositions
LT3592734T (lt) 2017-03-06 2021-07-26 Palobiofarma, S.L. (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska

Also Published As

Publication number Publication date
PT4121419T (pt) 2024-11-18
KR20220154791A (ko) 2022-11-22
EP3882240A1 (en) 2021-09-22
EP4121419B1 (en) 2024-08-14
ES3002084T3 (en) 2025-03-06
HRP20241515T1 (hr) 2025-01-03
HUE068886T2 (hu) 2025-02-28
SI4121419T1 (sl) 2025-02-28
WO2021185748A1 (en) 2021-09-23
LT4121419T (lt) 2024-11-25
RS66214B1 (sr) 2024-12-31
CN115298169B (zh) 2024-11-19
CN115298169A (zh) 2022-11-04
JP7779846B2 (ja) 2025-12-03
US20230183195A1 (en) 2023-06-15
CA3171894A1 (en) 2021-09-23
AU2021237686A1 (en) 2022-10-06
BR112022018449A2 (pt) 2022-11-01
US12384754B2 (en) 2025-08-12
AU2021237686B2 (en) 2026-04-09
PL4121419T3 (pl) 2025-02-17
FI4121419T3 (fi) 2024-11-04
CA3171894C (en) 2025-03-11
JP2023517722A (ja) 2023-04-26
MX2022011530A (es) 2022-10-13
ZA202211247B (en) 2023-12-20
EP4121419A1 (en) 2023-01-25

Similar Documents

Publication Publication Date Title
JP1739310S (ja) チャーム
DK3964969T3 (da) Opdeling af soc-arkitektur
SI3880654T1 (sl) 2-formil-3-hidroksifeniloksimetilne spojine, zmožne modulirati hemoglobin
DK3606909T3 (da) Natriumsalt af n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1h-pyrazol-3-sulfonamid
DK3937637T3 (da) Herbicidt virksomme 3-phenylisoxazolin-5-carboxamider af s-holdige cyclopentenylcarbonsyreestere
EP3891620A4 (en) TRANSACTIONAL STREAMING OF CHANGE TRACKING DATA
DK3784649T3 (da) Fremgangsmåde til syntese af (s)-3-amino-4-(difluormethylenyl)cyclopent-1-en-1-carboxylsyre
DK3737470T3 (da) 3-phenyl-4-hexynsyrederivater som gpr40-agonister
IL312496A (en) Crystalline forms of n-((1r,3s)-3-(4-acetylpiperazin-1-yl)cyclohexyl)-4-fluoro-7-methyl-1h-indole-2-carboxamide
EP4426827A4 (en) Modified Leucine Decarboxylases
IL305851A (en) Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid
IL287752A (en) Optimization of engineered meganucleases for recognition sequences
DK3592734T3 (da) Aminsalt af (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentancarboxylsyre
DK4097117T3 (da) Fremgangsmåde til fremstilling af nukleinsyreoligomer
DK4199922T3 (da) (1R,3S)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentan-1-carbonsyre til anvendelse i behandlingen af luftvejssygdomme
EP3995095A4 (en) HIGH FREQUENCY CLAMP
DK3856196T3 (da) Phenylpropionsyrederivater til modulation af patogen aktivitet
BR112017021336A2 (pt) método para produzir acilsulfamoilbenzamidas.
ZA202211247B (en) Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid
IL314508A (en) Theragnostic folate conjugates
HK40087530A (en) Cocrystals of(1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid
DK4441239T3 (da) Fremgangsmåde til fremstilling af l-cysteinsyre
HUP2200363A1 (hu) Eljárás (1r,4r)-4-helyettesített ciklohexán-1-aminok elõállítására
LT3980003T (lt) [((1r,2s,5r)-2-izopropil-5-metil-cikloheksankarbonil)-amino]-acto rūgšties izopropilo esteris, skirtas lėtinio kosulio gydymui
DK3459356T3 (da) Forbedret fremgangsmåde til produktion af blodmel